These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 347787)

  • 41. [Coumarin therapy during antirheumatism therapy with sulindac].
    Schenk H; Klein G; Haralambus I; Goebel R
    Z Rheumatol; 1980; 39(3-4):102-8. PubMed ID: 6968485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phenprocoumon requirement, whole blood coagulation time, bleeding time and plasma gamma-GT in patients receiving mianserin.
    Kopera H; Schenk H; Stulemeijer S
    Eur J Clin Pharmacol; 1978 Jul; 13(5):351-6. PubMed ID: 27373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic fate of phenprocoumon in humans.
    Toon S; Heimark LD; Trager WF; O'Reilly RA
    J Pharm Sci; 1985 Oct; 74(10):1037-40. PubMed ID: 4078699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of flunixin in the cat: enterohepatic circulation and active transport mechanism in the liver.
    Horii Y; Ikenaga M; Shimoda M; Kokue E
    J Vet Pharmacol Ther; 2004 Apr; 27(2):65-9. PubMed ID: 15096102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of cholestyramine on the gastrointestinal absorption of phenprocoumon and acetylosalicylic acid in man.
    Hahn KJ; Eiden W; Schettle M; Hahn M; Walter E; Weber E
    Eur J Clin Pharmacol; 1972 Jun; 4(3):142-5. PubMed ID: 4655288
    [No Abstract]   [Full Text] [Related]  

  • 46. Plasma hypercoagulability after termination of oral anticoagulants.
    Harenberg J; Haas R; Zimmermann R
    Thromb Res; 1983 Mar; 29(6):627-33. PubMed ID: 6857601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Heparin and phenprocoumon].
    Deutsch E
    Dtsch Med Wochenschr; 1978 Mar; 103(12):496. PubMed ID: 639670
    [No Abstract]   [Full Text] [Related]  

  • 48. Enhanced elimination of warfarin during treatment with cholestyramine.
    Jähnchen E; Meinertz T; Gilfrich HJ; Kersting F; Groth U
    Br J Clin Pharmacol; 1978 May; 5(5):437-40. PubMed ID: 656283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose-dependent metabolism and hepatic distribution of phenprocoumon in rats.
    Trenk D; Winkelmann B; Jähnchen E; Oie S
    J Pharmacokinet Biopharm; 1988 Feb; 16(1):1-12. PubMed ID: 3373415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Elimination kinetics of phenprocoumon (Marcumar) in liver cirrhosis and after premedication with phenobarbital].
    Heni N; Lehnhardt G; Glogner P
    Int J Clin Pharmacol Biopharm; 1976 Jun; 13(4):253-61. PubMed ID: 965132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The treatment basis for anticoagulants in horses].
    Sinn D; Wintzer HJ
    Tierarztl Prax; 1990 Oct; 18(5):507-11. PubMed ID: 2264055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pentoxifylline does not interfere with stable coumarin anticoagulant therapy: a clinical study.
    Ingerslev J; Mouritzen C; Stenbjerg S
    Pharmatherapeutica; 1986; 4(9):595-600. PubMed ID: 3763653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Drug interactions. Metoclopramide-phenprocoumon].
    Bruhn HD; Kirch W; Ohnhaus EE
    Dtsch Med Wochenschr; 1987 May; 112(18):742. PubMed ID: 3569068
    [No Abstract]   [Full Text] [Related]  

  • 54. Interaction of allopurinol with phenprocoumon in man.
    Jähnchen E; Meinertz I; Gilfrich HJ
    Klin Wochenschr; 1977 Aug; 55(15):759-61. PubMed ID: 895010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absence of interaction between ofloxacin and phenprocoumon.
    Verho M; Malerczyk V; Rosenkranz B; Grötsch H
    Curr Med Res Opin; 1987; 10(7):474-9. PubMed ID: 3476252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug interactions involving oral anticoagulants.
    O'Reilly RA
    Cardiovasc Clin; 1974; 6(2):23-41. PubMed ID: 4613460
    [No Abstract]   [Full Text] [Related]  

  • 57. Age-dependent differences in the effect of phenprocoumon on the vitamin K1-epoxide cycle in rats.
    Trenk D; Beermann D; Oesch F; Jähnchen E
    J Pharm Pharmacol; 1980 Dec; 32(12):828-32. PubMed ID: 6110746
    [No Abstract]   [Full Text] [Related]  

  • 58. [Increased effect of phenprocoumon (Marcumar) in nephrotic syndrome].
    Heni N; Völger R; Glogner P
    MMW Munch Med Wochenschr; 1980 Feb; 122(5):175-6. PubMed ID: 6767946
    [No Abstract]   [Full Text] [Related]  

  • 59. Interaction study between phenprocoumon and flurbiprofen.
    Marbet GA; Duckert F; Walter M; Six P; Airenne H
    Curr Med Res Opin; 1977; 5(1):26-31. PubMed ID: 913120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Probenecid affects liver metabolism].
    Bammel A; Mönig H; Zurborn KH; Ohnhaus EE; Kirch W
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1831-4. PubMed ID: 2609138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.